Bioxytran
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bioxytran generated cash of -$775,375, which is more than the previous year. Cash used in financing activities reached the amount of $550,361 last year. Net change in cash is therefore -$269,315.
Cash Flow
| 2014 | -16.32K | 0 | 1.8K |
|---|---|---|---|
| 2015 | -2.68K | 0 | -5.67K |
| 2016 | -42.38K | 0 | 50K |
| 2017 | -18.51K | 0 | 22.7K |
| 2018 | -185.90K | 0 | 222.20K |
| 2019 | -431.03K | 0 | 564.25K |
| 2020 | -1.09M | -10K | 981.05K |
| 2021 | -1.69M | -36.93K | 1.76M |
| 2022 | -1.80M | -32.24K | 2.06M |
| 2023 | -775.37K | -44.30K | 550.36K |
BIXT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 295.40K | 72.35K | 41.68K | 169.62K | 36.41K | 110 | 11.09K | 3.48K | 6.16K | 20.68K |
Operating activities | ||||||||||
Net income | -4.28M | -2.65M | -4.52M | -2.54M | -1.85M | -296.41K | -318.38K | -696.75K | -2.10M | -1.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.28K | 3.64K | 77.03K | 259.05M | 0 | 5.17K | 17.53K | 27.62K | 54.78K | 58.19K |
Stock-based compensation expense | 197.55K | 178.38K | 582.86K | 247.86K | 1.12M | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 197.55K | 178.38K | 582.86K | 247.86K | 1.12M | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 50K | -50K | 0 | -13.35K | -9.6K | 0 | -5.07K |
Inventories | 0 | 0 | 0 | -50K | 50K | 0 | 1.00K | -6.27K | 0 | 14.11K |
Accounts payable | 2.26M | 303.80K | 1.89M | 487.37K | 170.58K | 32.92K | 70.08K | 214.61K | 152.66K | 167.44K |
Cash generated by operating activities | -775.37K | -1.80M | -1.69M | -1.09M | -431.03K | -185.90K | -18.51K | -42.38K | -2.68K | -16.32K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -32.24K | -36.93K | -10K | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -44.30K | -32.24K | -36.93K | -10K | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 550.36K | 680K | 600K | 950K | 20K | 0 | 22.7K | 50K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.16M | -232.94K | 0 | 0 | 0 | 0 | 0 | -6K |
Cash used in financing activities | 550.36K | 2.06M | 1.76M | 981.05K | 564.25K | 222.20K | 22.7K | 50K | -5.67K | 1.8K |
Net Change In Cash | -269.31K | 223.04K | 30.67K | -127.94K | 133.21K | 36.30K | 4.18K | 7.61K | -2.68K | -14.52K |
Cash at end of period | 26.08K | 295.40K | 72.35K | 41.68K | 169.62K | 36.41K | 15.27K | 11.09K | 3.48K | 6.16K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |